Treatment with methotrexate is not associated with testicular toxicity Introduction Immune-mediated inflammatory diseases (often shortened to IMID) include rheumatoid arthritis, psoriatic arthritis, and psoriasis. These chronic inflammatory diseases can affect people of all ages, which can impact people’s decisions to start a family – and their treatment choices. There are many treatments available for IMIDs, […]
Category: Rheumatoid arthritis
New analysis to guide individualised assessment and clinical decision-making around use of tofacitinib in RA
Risks of cardiovascular disease or cancer on tofacitinib are higher in people aged 65 or older with a history of smoking Introduction Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability among other symptoms. Rheumatoid arthritis can affect people of all ages, but it most often starts […]
Real-world safety of b/tsDMARDS in the ARTIS registry
Currently available b/tsDMARDs have acceptable and on the whole similar safety profiles in a real-world population Introduction Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. It […]
After JAKi, cycling or switching appear to have similar effectiveness
This analysis provides new information about cycling JAKi or switching to a bDMARD after JAKi failure Introduction Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. It […]
Can anti-rheumatic treatments deliver cardiovascular protection?
People with rheumatoid arthritis have increased arterial inflammation that is responsive to effective treatments Introduction Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability among other symptoms. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. […]
Window of opportunity for managing fatigue
Many but not all people with rheumatoid arthritis achieve sustained fatigue improvement with intensive drug therapy, but early and effective treatment could mitigate this. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability among other symptoms. Rheumatoid arthritis can affect people of all ages, but it […]
Barriers to fulfilling patient education recommendations
Common barriers to providing recommended patient education are lack of time or training. INTRODUCTION Inflammatory arthritis is a group of diseases including spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis. These are chronic inflammatory diseases that affects a person’s joints, and may cause pain and disability. Patient education is a planned interactive learning process designed to support […]
Updated: Managing RA
This is the lay version of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, Landewé RBM, Bergstra SA, et alEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: […]
Inflammation correlates with PROs in early RA
In the early phases inflammatory variables directly correlate with the PGA across different disease activity states INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. […]
New: EULAR Points to consider for remote care in RMDs
This is the lay version of the EULAR points to consider for remote care in people with rheumatic and musculoskeletal diseases. The original publication can be downloaded from the EULAR website: www.eular.org. De Thurah A, Bosch P, Marques A, et al2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases Annals of […]
